ABBOTT LABORATORIES — Director's Dealing 2007

Aug 9, 2007

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2007-08-07

Reporting Person: Landgraf John C (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2007-08-07	Common shares without par value	M	8185	$41.0317	Acquired	104737	Direct
2007-08-07	Common shares without par value	M	5621	$42.42	Acquired	110358	Direct
2007-08-07	Common shares without par value	F	11992	$53.12	Disposed	98366	Direct
2007-08-08	Common shares without par value	M	13607	$42.4978	Acquired	111973	Direct
2007-08-08	Common shares without par value	M	15409	$42.83	Acquired	127382	Direct
2007-08-08	Common shares without par value	F	25255	$54.30	Disposed	102127	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2007-08-07	Option (right to buy)	$41.0317	M	8185	Disposed	2014-02-19	Common shares (8185)	Direct
2007-08-07	Option (right to buy)	$42.42	M	5621	Disposed	2013-02-13	Common shares (5621)	Direct
2007-08-07	Option (right to buy)	$53.12	A	7057	Acquired	2014-02-19	Common shares (7057)	Direct
2007-08-07	Option (right to buy)	$53.12	A	4935	Acquired	2013-02-13	Common shares (4935)	Direct
2007-08-08	Option (right to buy)	$42.4978	M	13607	Disposed	2009-02-11	Common shares (13607)	Direct
2007-08-08	Option (right to buy)	$42.83	M	15409	Disposed	2013-02-13	Common shares (15409)	Direct
2007-08-08	Option (right to buy)	$54.30	A	11816	Acquired	2009-02-11	Common shares (11816)	Direct
2007-08-08	Option (right to buy)	$54.30	A	13439	Acquired	2013-02-13	Common shares (13439)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	15308	Indirect
Common shares without par value	25000	Indirect
Common shares without par value	885	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of August 7, 2007

F2: Held in the Anne Marie Landgraf Living Trust. The reporting person and his spouse are co-trustees of the trust. The trust is revocable by his spouse.

F3: Includes shares acquired under the Abbott Laboratories Dividend Re-investment and Stock Purchase Plan in transactions exempt from Section 16 under Rule 16a-(11)

F4: Reporting person disclaims beneficial ownership of all securities held by his son.

F5: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3.

F6: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3.